Cigna Group
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
CI$293.59-2.6%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
FS-3
BALANCE SHEETS
| As of December 31, | |||
|---|---|---|---|
| (In millions) | 2023 | 2022 (1) | |
| Assets | |||
| Cash and cash equivalents | $303 | $115 | |
| Other current assets | 6 | 6 | |
| Total current assets | 309 | 121 | |
| Investments in subsidiaries | 69,703 | 70,679 | |
| Intercompany receivable | 11,475 | 10,366 | |
| Other non-current assets | 77 | 99 | |
| TOTAL ASSETS | $81,564 | $81,265 | |
| Liabilities | |||
| Short-term debt | $2,448 | $2,749 | |
| Other current liabilities | 1,854 | 1,295 | |
| Total current liabilities | 4,302 | 4,044 | |
| Long-term debt | 27,151 | 26,815 | |
| Intercompany payable | 3,874 | 5,705 | |
| Other non-current liabilities | 14 | 26 | |
| TOTAL LIABILITIES | 35,341 | 36,590 | |
| Shareholders' Equity | |||
| Common stock (shares issued, 400 and 398; authorized, 600) | 4 | 4 | |
| Additional paid-in capital | 30,669 | 30,233 | |
| Accumulated other comprehensive loss | (1,864) | (1,658) | |
| Retained earnings | 41,652 | 37,940 | |
| Less treasury stock, at cost | (24,238) | (21,844) | |
| TOTAL SHAREHOLDERS' EQUITY | 46,223 | 44,675 | |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $81,564 | $81,265 | |
FS-3
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.